Showing results (91-100 of 265) with videos related to
Sort By:
Pageof 27
Medical Interface|March 8, 1996
Episode treatment groups: an illness classification and episode building system--Part IID K Dang, J M Pont, M A PortmoyAntimicrobial Agents and Chemotherapy|September 1, 1987
Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosidesJ M Gatell, F Ferran, V Araujo, et al.Medicina Clinica|May 23, 1992
[Nephropathy in human immunodeficiency virus infection]N Esforzado, T Feliz, J Almirall, et al.The Journal of Antimicrobial Chemotherapy|September 4, 2014
Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adultsL Egaña-Gorroño, E Martínez, I Pérez, et al.Medicina Clinica|April 22, 1989
[Prevalence of tuberculous infection among health personnel]T Puyuelo Lanao, E Hernández Martínez, J M Gatell Artigas, et al.Menopause (New York, N.Y.)|March 21, 2001
Implications of the FMR1 gene in menopause: study of 147 Spanish womenJ Mallolas, M Duran, A Sánchez, et al.Medicina Clinica|January 6, 2001
[Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma]Mercè Alsina M, F Bulla, C Conill, et al.The British Journal of Dermatology|April 1, 1980
Acute and chronic graft-vs-host reaction in skin: report of two casesJ M Mascaro, C Rozman, J Palou, et al.Journal of the Neurological Sciences|September 10, 1997
Skeletal muscle studies in patients with HIV-related wasting syndromeO Miró, E Pedrol, M Cebrián, et al.Molecular and Cellular Probes|May 9, 2000
Rare variants in the promoter of the fragile X syndrome gene (FMR1)M Milà, S Castellví-Bel, A Sánchez, et al.Pageof 27